GLP-1 Medications Show Medical Cost Benefits, With Adherence and Women’s Health as Key Factors
Risk & Insurance - Jan 19, 2026
Aon study shows slower medical cost growth for GLP-1 users, yet employers face complex decisions on coverage amid evolving pricing, health patterns. The post GLP-1 Medications Show Medical Cost Benefits, With Adherence and Women’s Health as Key Factors appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Mar 04, 2026
As data-only extortion surged to 65% of cases in the second half of 2025, organizations face reputat...
Posted: Mar 04, 2026
Allianz survey finds more than half of risk managers view cascading supply chain disruptions as the...
Posted: Mar 03, 2026
Delaying adoption creates real competitive risk, widening gaps in severity management, settlement ou...